Management Team

Helen R. Park, M.S., CEO
Helen R. Park, CEO, Board of Directors, Power3 Medical Products, Inc. (09, 2009-present) is a serial entrepreneur, with 40 plus years in Science and Bio Technology business management. She founded Advanced Bio/Chem in 2000, and served as Chief Executive Officer and Chairman of the Board, through June 2004. Ms. Park is founder and CEO of Bronco Technology Inc., a contracting and consulting firm for bio-technology companies. Ms. Park has served as president and on various professional boards. She has an M.S. in Biochemistry from Baylor College of Medicine.

John Ginzler, B.S., MBA., Chief Financial Officer
On April 29, 2009, Mr. John P. Ginzler was named Chief Financial Officer of Power 3 Medical Products, Inc. Mr. Ginzler brings nearly 20 years of experience in the medical industry to Power 3. Previously, Mr. Ginzler served as Vice President, Finance of Critical Care Systems, Inc. since 2006. Prior to 2006, Mr. Ginzler served as Director of Accounting for Critical Care Systems. Mr. Ginzler has an MBA in Entrepreneurship, Cum Laude, from Babson College and a BS in Accounting, Summa Cum Laude, from Northeastern University.

Ira L. Goldknopf, Ph.D., Director, Chief Scientific Officer
Dr. Goldknopf has over 30 years of proteomic experience. He is a well recognized pioneer and leader in Proteomics, having produced, the first isolation, identification and sequencing of a new protein spot on a 2D gel. He also discovered ubiquitin conjugation of proteins, which laid the groundwork for the 2000 Lasker award. He was cofounder of ProteEx in 2000 and prior to that was founding CEO of UbiquiTex Technologies, and cofounder and VP of R&D of FlowGenix Corporation. His experience also includes Manager GMP, QC/QA, and analytical operations, GAF/ISP and Triplex Pharmaceuticals. He spent 10 years on the faculty of Baylor College of Medicine and a sabbatical year at the Medical Nobel Institute, Karolinska Institute, Stockholm, Sweden. He is the author of more than 70 publications and also serves on the Scientific Advisory Board of the Company.